Primera bags $11m in series A:
This article was originally published in Clinica
Executive Summary
Developer of gene expression analysis systems and assays Primera Biosystems has raised $11m in a series A financing round. Investors in the Providence, Rhode Island firm include MPM Capital, Burrill and Company and the Malaysian Technology Development Corporation. Primera said the funds will enable it to develop products based on its proprietary STAR (scalable transcription analysis routine) technology, which combines real-time PCR and DNA microarray technologies in one single system.